NOS1 and type 1 diabetes mellitus: In support of our findings in type 2 diabetes, Bujalska et al reported that intrathecal administration of a specific inhibitor of iNOS, but not neuronal NOS, prevents hyperalgesia in STZ-induced type 1 diabetes [40].